Growth Metrics

InfuSystem Holdings (INFU) EBITDA (2016 - 2025)

InfuSystem Holdings (INFU) has disclosed EBITDA for 16 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 61.1% year-over-year to $2.0 million, compared with a TTM value of $6.1 million through Dec 2025, up 155.6%, and an annual FY2025 reading of $6.1 million, up 155.6% over the prior year.
  • EBITDA was $2.0 million for Q4 2025 at InfuSystem Holdings, down from $2.2 million in the prior quarter.
  • Across five years, EBITDA topped out at $2.4 million in Q2 2025 and bottomed at -$904000.0 in Q1 2024.
  • Average EBITDA over 5 years is $592350.0, with a median of $654000.0 recorded in 2021.
  • Peak annual rise in EBITDA hit 2790.48% in 2023, while the deepest fall reached 15700.0% in 2023.
  • Year by year, EBITDA stood at $585000.0 in 2021, then tumbled by 100.51% to -$3000.0 in 2022, then tumbled by 15700.0% to -$474000.0 in 2023, then skyrocketed by 356.54% to $1.2 million in 2024, then surged by 61.1% to $2.0 million in 2025.
  • Business Quant data shows EBITDA for INFU at $2.0 million in Q4 2025, $2.2 million in Q3 2025, and $2.4 million in Q2 2025.